Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Status:
Not yet recruiting
Trial end date:
2030-01-11
Target enrollment:
Participant gender:
Summary
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients
based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon
cancer.